Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Aug 30;12(8):1658-1660.
doi: 10.21037/tlcr-23-419. Epub 2023 Aug 4.

T-cell responses to small cell lung cancer: the immune system and the tumor are two sides of the same coin

Bernard A M Van der Zeijst  1   2
Affiliations
Editorial

T-cell responses to small cell lung cancer: the immune system and the tumor are two sides of the same coin

Bernard A M Van der Zeijst. Transl Lung Cancer Res. .
No abstract available

Keywords: Small cell lung cancer (SCLC); T-cell receptor (TCR); cytotoxic T-cells; immune checkpoint inhibitors (ICIs); immunotherapy.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at https://tlcr.amegroups.com/article/view/10.21037/tlcr-23-419/coif). The author reports that he is the CSO of Catherinn, a startup involved in research on SCLC, and owns stock in Catherinn. The author has no other conflicts of interest to declare.

Figures

Figure 1
Figure 1
Transcriptional subtypes of SCLC. Data from (8). The distribution is approximate, dependent on the selection of SCLC samples. SCLC, small cell lung cancer.
See this image and copyright information in PMC

Comment on

Similar articles

See all similar articles

References

    1. Balbach ML, Axelrod ML, Balko JM, et al. Peripheral T-cell receptor repertoire dynamics in small cell lung cancer. Transl Lung Cancer Res 2023;12:257-65. 10.21037/tlcr-22-666 - DOI - PMC - PubMed
    1. Han J, Duan J, Bai H, et al. TCR Repertoire Diversity of Peripheral PD-1(+)CD8(+) T Cells Predicts Clinical Outcomes after Immunotherapy in Patients with Non-Small Cell Lung Cancer. Cancer Immunol Res 2020;8:146-54. 10.1158/2326-6066.CIR-19-0398 - DOI - PubMed
    1. Valpione S, Mundra PA, Galvani E, et al. The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival. Nat Commun 2021;12:4098. 10.1038/s41467-021-24343-x - DOI - PMC - PubMed
    1. Li L, Liang Y, Yu M, et al. Advances in immune checkpoint inhibitors therapy for small cell lung cancer. Cancer Med 2023;12:11097-106. 10.1002/cam4.5659 - DOI - PMC - PubMed
    1. Rudin CM, Brambilla E, Faivre-Finn C, et al. Small-cell lung cancer. Nat Rev Dis Primers 2021;7:3. 10.1038/s41572-020-00235-0 - DOI - PMC - PubMed